Kent A - Search Results

1

Beyond αβ T cells: NK, iNKT, and γδT cell biology in leukemic patients and potential for off-the-shelf adoptive cell therapies for AML.

Kent A, Crump LS, Davila E. Kent A, et al. Front Immunol. 2023 Aug 15;14:1202950. doi: 10.3389/fimmu.2023.1202950. eCollection 2023. Front Immunol. 2023. PMID: 37654497 Free PMC article. Review.

2

Naturally Occurring Genetic Alterations in Proximal TCR Signaling and Implications for Cancer Immunotherapy.

Kent A, Longino NV, Christians A, Davila E. Kent A, et al. Front Immunol. 2021 May 3;12:658611. doi: 10.3389/fimmu.2021.658611. eCollection 2021. Front Immunol. 2021. PMID: 34012443 Free PMC article. Review.

3

Chimeric non-antigen receptors in T cell-based cancer therapy.

Guo J, Kent A, Davila E. Guo J, et al. Among authors: kent a. J Immunother Cancer. 2021 Aug;9(8):e002628. doi: 10.1136/jitc-2021-002628. J Immunother Cancer. 2021. PMID: 34344725 Free PMC article. Review.

4

Glasdegib as maintenance therapy for patients with AML and MDS patients at high risk for postallogeneic stem cell transplant relapse.

Kent A, Vasu S, Schatz D, Monson N, Devine S, Smith C, Gutman JA, Pollyea DA. Kent A, et al. Blood Adv. 2020 Jul 14;4(13):3102-3108. doi: 10.1182/bloodadvances.2020001991. Blood Adv. 2020. PMID: 32634235 Free PMC article.

5

Treatment-free remission after ceasing venetoclax-based therapy in patients with acute myeloid leukemia.

Chua CC, Hammond D, Kent A, Tiong IS, Konopleva MY, Pollyea DA, DiNardo CD, Wei AH. Chua CC, et al. Among authors: kent a. Blood Adv. 2022 Jul 12;6(13):3879-3883. doi: 10.1182/bloodadvances.2022007083. Blood Adv. 2022. PMID: 35511730 Free PMC article.

6

Nod-like receptors: key molecular switches in the conundrum of cancer.

Kent A, Blander JM. Kent A, et al. Front Immunol. 2014 Apr 23;5:185. doi: 10.3389/fimmu.2014.00185. eCollection 2014. Front Immunol. 2014. PMID: 24795727 Free PMC article. Review.

7

Atraumatic Splenic Rupture due to Chronic Myelomonocytic Leukemia Treated with Partial Splenic Artery Embolization.

Nie Y, Kent A, Do M, Amaya M, Klein C, Thienelt C. Nie Y, et al. Among authors: kent a. Case Rep Oncol. 2022 Mar 21;15(1):277-284. doi: 10.1159/000522663. eCollection 2022 Jan-Apr. Case Rep Oncol. 2022. PMID: 35529292 Free PMC article.

8

Long Non-coding RNA MALAT1 Is Depleted With Age in Skeletal Muscle in vivo and MALAT1 Silencing Increases Expression of TGF-β1 in vitro.

Ruan L, Mendhe B, Parker E, Kent A, Isales CM, Hill WD, McGee-Lawrence M, Fulzele S, Hamrick MW. Ruan L, et al. Among authors: kent a. Front Physiol. 2022 Jan 21;12:742004. doi: 10.3389/fphys.2021.742004. eCollection 2021. Front Physiol. 2022. PMID: 35126169 Free PMC article.

9

Hindlimb Immobilization Increases IL-1β and Cdkn2a Expression in Skeletal Muscle Fibro-Adipogenic Progenitor Cells: A Link Between Senescence and Muscle Disuse Atrophy.

Parker E, Khayrullin A, Kent A, Mendhe B, Youssef El Baradie KB, Yu K, Pihkala J, Liu Y, McGee-Lawrence M, Johnson M, Chen J, Hamrick M. Parker E, et al. Among authors: kent a. Front Cell Dev Biol. 2022 Jan 3;9:790437. doi: 10.3389/fcell.2021.790437. eCollection 2021. Front Cell Dev Biol. 2022. PMID: 35047502 Free PMC article.

10

A central role for Notch in effector CD8(+) T cell differentiation.

Backer RA, Helbig C, Gentek R, Kent A, Laidlaw BJ, Dominguez CX, de Souza YS, van Trierum SE, van Beek R, Rimmelzwaan GF, ten Brinke A, Willemsen AM, van Kampen AH, Kaech SM, Blander JM, van Gisbergen K, Amsen D. Backer RA, et al. Among authors: kent a. Nat Immunol. 2014 Dec;15(12):1143-51. doi: 10.1038/ni.3027. Epub 2014 Oct 26. Nat Immunol. 2014. PMID: 25344724 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

988 results

Search Page